Very-Low-Dose Pegylated Interferon α2a Plus Ribavirin Therapy for Advanced Liver Cirrhosis Type C: A Possible Therapeutic Alternative without Splenic Intervention

Publisher: Karger

E-ISSN: 1662-0631|4|2|261-266

ISSN: 1662-0631

Source: Case Reports in Gastroenterology, Vol.4, Iss.2, 2010-07, pp. : 261-266

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content